Racotumomab therapeutic vaccine in an elderly with advanced lung cancer

Abstract

The case report of a 84 years elderly smoker, is presented with diagnosis of lung cancer in stage IV who was included in the phase III clinical trial to be treated with racotumomab. Clinical improvement and recovery of the patient's general state was observed, because according to the functional scale the study concluded with ECOG 0. Therefore, it is opportune to highlight that this vaccine increases the survival of those affected by recurrent non-small cells lung cancer or in advanced stages.

Keywords

• anciano
• cáncer de pulmón de células no pequeñas
• vacuna terapéutica
• racotumomab
• ensayo clínico en fase iii
• supervivencia.